{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:33:31Z","timestamp":1783028011955,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1348,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.bbmt.2010.12.705","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T04:46:26Z","timestamp":1294375586000},"page":"1237-1244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["ATG Prevents Severe Acute Graft-versus-Host Disease in Mismatched Unrelated Donor Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"17","author":[{"given":"Joseph","family":"Pidala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcie","family":"Tomblyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiga","family":"Nishihori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Alsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Leonel","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Conwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Bookout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Anasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.12.705_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bmt.1704758","article-title":"Antilymphocyte\/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects","volume":"35","author":"Bacigalupo","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin:T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.12.705_bib3","doi-asserted-by":"crossref","unstructured":"Bacigalupo A, Lamparelli T, Milone G, et\u00a0al. Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants. Bone Marrow Transplant, 45:385-391.","DOI":"10.1038\/bmt.2009.151"},{"key":"10.1016\/j.bbmt.2010.12.705_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bmt.1703306","article-title":"Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)","volume":"28","author":"Bacigalupo","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib5","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/blood-2006-08-013995","article-title":"A phase 2\/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease","volume":"109","author":"Macmillan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.12.705_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002770050310","article-title":"ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival","volume":"75","author":"Dugan","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2010.12.705_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/bbmt.2002.v8.pm11939605","article-title":"Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment","volume":"8","author":"Arai","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.bmt.1703032","article-title":"Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin","volume":"27","author":"Khoury","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/bbmt.2002.v8.pm11858189","article-title":"Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease","volume":"8","author":"MacMillan","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib10","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood.V77.8.1821.1821","article-title":"A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment","volume":"77","author":"Martin","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.12.705_bib11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.exphem.2008.03.011","article-title":"Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors","volume":"36","author":"Ayuk","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2010.12.705_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/sj.bmt.1703674","article-title":"Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis","volume":"30","author":"Duggan","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.bbmt.2009.02.010","article-title":"Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia","volume":"15","author":"Kim","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbmt.2009.01.002","article-title":"HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen","volume":"15","author":"Kroger","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1704157","article-title":"ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)","volume":"32","author":"Zander","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib16","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood.V98.10.2942","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)","volume":"98","author":"Bacigalupo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.12.705_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1056\/NEJM198202183060703","article-title":"A randomized study of the prevention of acute graft-versus-host disease","volume":"306","author":"Ramsay","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2010.12.705_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00007890-197904000-00003","article-title":"Antihuman thymocyte globulin for prophylaxis of graft-versus-host disease. A randomized trial in patients with leukemia treated with HLA-identical sibling marrow grafts","volume":"27","author":"Weiden","year":"1979","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2010.12.705_bib19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","article-title":"Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial","volume":"10","author":"Finke","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2010.12.705_bib20","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1182\/blood-2006-10-052308","article-title":"Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens","volume":"109","author":"Champlin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.12.705_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/bmt.2008.244","article-title":"Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT","volume":"42","author":"Toor","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bmt.1704135","article-title":"Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML","volume":"32","author":"Schleuning","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.bmt.1704138","article-title":"Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML","volume":"32","author":"Bonifazi","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib24","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/01.TP.0000065737.60591.9D","article-title":"Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell-depleted bone marrow transplantation: a comparison between recipients of matched related and matched unrelated donor grafts","volume":"75","author":"Meijer","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2010.12.705_bib25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1200\/JCO.2003.03.129","article-title":"Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin","volume":"21","author":"Finke","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.12.705_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bmt.1703374","article-title":"Association between pretransplant thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors","volume":"29","author":"Remberger","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbmt.2008.03.010","article-title":"Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia\/lymphoma: impact of antithymocyte globulin on clinical outcome","volume":"14","author":"Tanosaki","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bmt.1704940","article-title":"In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study","volume":"35","author":"Bonifazi","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1053\/bbmt.2002.v8.abbmt080656","article-title":"Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants","volume":"8","author":"Bacigalupo","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib31","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood.V96.8.2703.h8002703_2703_2711","article-title":"Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation","volume":"96","author":"Thomson","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.12.705_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/152581603321628377","article-title":"Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation","volume":"12","author":"Fehse","year":"2003","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.bbmt.2010.12.705_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.bmt.1704089","article-title":"High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment","volume":"32","author":"Juvonen","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib34","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.12.705_bib35","article-title":"Strategies to prevent EBV reactivation and post-transplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high risk patients","author":"Reddy","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib36","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood.V98.4.972","article-title":"Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell\u00a0transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT","volume":"98","author":"van Esser","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.12.705_bib37","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/TP.0b013e31819f1c49","article-title":"Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation","volume":"87","author":"Ahmad","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2010.12.705_bib38","doi-asserted-by":"crossref","unstructured":"Blaes AH, Cao Q, Wagner JE, Young JA, Weisdorf DJ, Brunstein CG. Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation. Biol Blood Marrow Transplant. 16:287-291.","DOI":"10.1016\/j.bbmt.2009.10.008"},{"key":"10.1016\/j.bbmt.2010.12.705_bib39","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1182\/blood.V99.12.4364","article-title":"Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation","volume":"99","author":"van Esser","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.12.705_bib40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bmt.1705289","article-title":"Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development","volume":"37","author":"Weinstock","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbmt.2008.05.023","article-title":"Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation","volume":"14","author":"Ayuk","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib42","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbmt.2009.07.006","article-title":"Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies","volume":"15","author":"Hamadani","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib43","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0301-472X(03)00204-2","article-title":"Antithymocyteglobulin as prophylaxis of graft failure and graft-versus-host disease in recipients of partially T-cell-depleted grafts from matched unrelated donors: a dose-finding study","volume":"31","author":"Meijer","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2010.12.705_bib44","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib45","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.12.705_bib46","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.bbmt.2010.12.705_bib47","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199904150-00013","article-title":"A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients","volume":"67","author":"Brennan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2010.12.705_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00007890-199807150-00005","article-title":"Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation","volume":"66","author":"Gaber","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2010.12.705_bib49","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/TP.0b013e318187bc67","article-title":"A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results","volume":"86","author":"Hardinger","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2010.12.705_bib50","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.12.705_bib51","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood.V108.11.2922.2922","article-title":"Pilot trial of rituximab for the prevention of Epstein Barr Virus B cell lymphoproliferative disorder (EBV-LPD) following T cell depleted (TCD) unrelated or HLA-mismatched related hemato-poietic stem cell transplantation","volume":"108","author":"Small","year":"2006","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110013054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110013054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:39:09Z","timestamp":1761057549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110013054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1083879110013054"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.12.705","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATG Prevents Severe Acute Graft-versus-Host Disease in Mismatched Unrelated Donor Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.12.705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}